About Spheryx
Spheryx is a company based in New York (United States) founded in 2014. Spheryx has raised $1.78 million across 10 funding rounds from investors including HHS, America’s Seed Fund and National Science Foundation. Spheryx offers products and services including xSight, xCell, xStream, and Compliant Software Suite. Spheryx operates in a competitive market with competitors including Halo Labs, Biotrack, Nexceloms, TACount and Nexcelom Bioscience, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spheryx, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.78 M (USD)
in 10 rounds
-
Latest Funding Round
$675 K (USD), Seed
Apr 14, 2023
-
Investors
HHS
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spheryx
Spheryx offers a comprehensive portfolio of products and services, including xSight, xCell, xStream, and Compliant Software Suite.
Tool for holographic analysis of sub-visible particles in suspensions.
System for analyzing cell viability in biologic and research applications.
Service for characterizing particles in industrial and academic contexts.
Suite for user-friendly interface in holographic data processing.
People of Spheryx
Unlock access to complete
Unlock access to complete
Funding Insights of Spheryx
Spheryx has successfully raised a total of $1.78M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $675 thousand completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Seed — $675,000
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Seed - Spheryx | Valuation |
investors |
|
| Dec, 2018 | Amount | Seed - Spheryx | Valuation |
investors |
|
| Sep, 2016 | Amount | Grant - Spheryx | Valuation |
investors |
Investors in Spheryx
Spheryx has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, America’s Seed Fund and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Research is conducted to advance translational science for health solutions.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spheryx
Financial Statements - Spheryx
Spheryx Comparisons
Competitors of Spheryx
Spheryx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Biotrack, Nexceloms, TACount and Nexcelom Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of subvisible particle analyzer for life science and materials applications
|
|
| domain | founded_year | HQ Location |
Rapid microbial detection and identification system
|
|
| domain | founded_year | HQ Location |
Specializes in automated cell counting and analysis expertise.
|
|
| domain | founded_year | HQ Location |
Specializes in imaging-based technology for microbiological testing.
|
|
| domain | founded_year | HQ Location |
Automated cell counting and imaging solutions are developed for cytometry.
|
Latest news on Spheryx
Frequently Asked Questions about Spheryx
Spheryx was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Spheryx is headquartered in New York, United States. It is registered at New York, New York, United States.
Spheryx is a funded company, having raised a total of $1.78M across 10 funding rounds to date. The company's 1st funding round was a Grant of $1.27M, raised on Mar 04, 2015.
Spheryx was founded in 2014 in New York, United States, within the analytical instruments sector. Patented technologies including Total Holographic Characterization and Holographic Video Microscopy are employed to create devices for non-destructive analysis of suspended particles such as colloidal microspheres, emulsion droplets, and nanoparticles. Precision and reproducibility are provided for applications in biopharmaceuticals, semiconductors, medical diagnostics, manufacturing controls, consumer products, and wastewater testing.
Spheryx's top competitors include Halo Labs, Spectradyne and Biotrack.
Spheryx offers xSight, xCell, xStream, and Compliant Software Suite.
Spheryx has 4 investors. Key investors include HHS, America’s Seed Fund, National Science Foundation, and National Center for Advancing Translational Sciences.